StockNews.com Initiates Coverage on Titan Pharmaceuticals (NASDAQ:TTNP)
Investment analysts at StockNews.com initiated coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Get Free Report) in a research report issued to clients and investors on Friday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Price Performance Titan Pharmaceuticals stock opened at $3.81 on Friday. The business’s fifty day […]
Investment analysts at StockNews.com initiated coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Get Free Report) in a research report issued to clients and investors on Friday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Price Performance Titan Pharmaceuticals stock opened at $3.81 on Friday. The business’s fifty day […]
